Member Info for Timster

I think its fair to say that Avacta will make a LOT of money from the LFT

As I said the other day I think clinical validation is pretty much a given. Considering the quality of Affimers already in two other highly accurate tests.

thats a new one for the Al "timescales for dummies" - Immediate

that must be better than few weeks, shortly, in a while.... ;)

I think its fair to say Avacta KNOW they have THE test that the world will want. They are supremely confident of its quality, just a matter of time now until more manufacturers on board and the first 10k get validated....

nah excel will only do 1048576 rows by 16384 columns, nowhere near enough ;)

come on the yanks pile in! don't be shy

Avacta might start throwing in a few afternoon RNS's once more US investors are on board. (Before the NASDAQ listing anyway)

casino always wins @chengdo buy and hold in Avacta's case the daily pattern of dropping in the morning has gone as people have seen the MASSIVE potential

here we go :)

from director talk Q&A

You announced the other day that you’ve appointed Stifel as joint broker, can you comment further on that?

Well, Stifel provide us with additional life sciences specialist sales capability and a strong US capital markets reach so that will help us to continue the work that I’ve been doing over the last 18 months or so in the US getting Avacta Group’s technology platforms known and attracting US investment.

ah yeah 137! is 220.07 the new price ex China?

wondered where he was. I do miss the derampers especially alwayswhinning ....

I remember 147 was our nemesis ;)

lets hope this brings some more large investors on board from the USA

I see where you are coming from @pigster and yes initially we will have a CE marked professional use LFT but in parallel they will be working on self test certification. As per the last presentation:

SARS-CoV-2 rapid antigen test
• Aiming for clinical validation 4Q20
• Initial CE self-certification for professional use
• CE marking for consumer self-testing running in parallel
• Additional commercial opportunities for SARS-CoV-2 spike protein Affimers

https://avacta.com/wp-content/uploads/2020/09/Avacta-Group-plc-Interim-Results-September-2020-v2.pdf

come on @pigster we know there aren't many LFT's to evaluated we also know the market is insanely large!

Not till 14.30 tomorow though... :)

I have a feeling that the pilot batch of LFT's for validation is closer than we think. Could be wrong but just the way the government is speaking makes me feel that way...

Still think we would have had a second RNS to confirm if they were using our covid Affimers

Derbyone Well spotted that RNS states they have access to Affimers

If mologic were using Affimers it would have been RNS'd like the other SKIN collaboration so I'm sure they are not.

What I do know though Q4 is off to a flyer.....